Biomarkers of gluten sensitivity in patients with non-affective psychosis: A meta-analysis

@article{Lachance2014BiomarkersOG,
  title={Biomarkers of gluten sensitivity in patients with non-affective psychosis: A meta-analysis},
  author={L. Lachance and K. McKenzie},
  journal={Schizophrenia Research},
  year={2014},
  volume={152},
  pages={521-527}
}
BACKGROUND Dohan first proposed that there may be an association between gluten sensitivity and schizophrenia in the 1950s. Since then, this association has been measured using several different serum biomarkers of gluten sensitivity. At this point, it is unclear which serum biomarkers of gluten sensitivity are elevated in patients with schizophrenia. However, evidence suggests that the immune response in this group is different from the immune response to gluten found in patients with Celiac… Expand
A review on the relationship between gluten and schizophrenia: Is gluten the cause?
TLDR
There were no consistent results in the clinical, immunological, microbiological, and epidemiological studies that investigated the relationship between schizophrenia and celiac disease, and a need for a larger scale study to confirm the presence of this suggested correlation. Expand
The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia
TLDR
The association between intestinal permeability and inflammation in the schizophrenic patients only was noted and the risk for developing schizophrenia was 4.35 (95% confidence interval) for AGA IgA and 3.39 for positive AGA IgG. Expand
Gluten Psychosis: Confirmation of a New Clinical Entity
TLDR
It is confirmed that psychosis may be a manifestation of non-celiac gluten sensitivity, and may also involve children; the diagnosis is difficult with many cases remaining undiagnosed. Expand
Gluten related illnesses and severe mental disorders: a comprehensive review
TLDR
There is insufficient evidence to recommend gluten‐free diets for populations with psychosis and mood disorders, and the literature review reveals significant inaccuracies in the data. Expand
Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review.
TLDR
All of the included studies found that a GFD is well tolerated and can be adhered to by patients with schizophrenia, and further research is required to examine the biomarkers of gluten sensitivity and inflammation to effectively target those patients with schizophrenia who will benefit most from this dietary intervention. Expand
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
TLDR
Overall the vast literature of peripheral biomarkers for major mental disorders is affected by bias and is underpowered, and no convincing evidence supported the existence of a trans-diagnostic biomarker. Expand
Addressing the Gastrointestinal Health Associated With Schizophrenia: the Argument For A New Nutrition-based Intervention
TLDR
The purpose of this paper is to review the literature linking schizophrenia with chronic inflammation and gluten sensitivity, and the need for dietary interventions that may improve multiple health outcomes for patients. Expand
Diet and Psychosis: A Scoping Review
TLDR
Dietary recommendations are presented as well as recommendations for further research including more prospective observational studies and intervention studies that modify diet constituents or entire dietary patterns with statistical power to detect mental health outcomes. Expand
The brain-gut axis dysfunctions and hypersensitivity to food antigens in the etiopathogenesis of schizophrenia.
TLDR
Research results seem to be very promising and indicate the possibility of improved clinical outcomes in some patients with schizophrenia by modifying diet, use of probiotics, and the implementation of antibiotic therapy of specific treatment groups, however, further research is needed on links between the intestinal microbiome and intestinal function as factors mediating the activation of the immune system. Expand
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
TLDR
Combining biomarkers and large-scale use of “bottom-up” approaches to biomarker identification are likely to maximize the eventual clinical utility of antibody biomarkers in psychotic disorders. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 34 REFERENCES
Markers of Gluten Sensitivity and Celiac Disease in Recent-Onset Psychosis and Multi-Episode Schizophrenia
TLDR
Individuals with recent-onset psychosis and with multi-episode schizophrenia who have increased antibodies to gliadin may share some immunologic features of celiac disease, but their immune response togliadin differs from that of Celiac disease. Expand
Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.
Celiac disease (CD) and schizophrenia have approximately the same prevalence, but epidemiologic data show higher prevalence of CD among schizophrenia patients. The reason for this higherExpand
“Bread madness” revisited: screening for specific celiac antibodies among schizophrenia patients
TLDR
There is no evidence for celiac disease in patients with chronic schizophrenia as manifested by the presence of serum IgA anti-endomysial antibodies, and it is unlikely that there is an association between gluten sensitivity and schizophrenia. Expand
Markers of gluten sensitivity and celiac disease in bipolar disorder.
TLDR
Evidence of increased levels of IgG antibodies to gliadin in the bipolar disorder population is found, however, such antibody increase is not accompanied by an elevation in IgA antibodies togliadin or the celiac disease-associated antibodies against deamidated Gliadin and tTG. Expand
Novel immune response to gluten in individuals with schizophrenia
TLDR
Findings indicate that the anti-gliadin immune response in schizophrenia has a different antigenic specificity from that in celiac disease and is independent of the action of transglutaminase enzyme and HLA-DQ2/DQ8. Expand
New understanding of gluten sensitivity
TLDR
Patients complain of IBS-like symptoms and extraintestinal manifestations that occur shortly after the ingestion of gluten, and symptoms improve or disappear when gluten is withdrawn from the diet, and recur if gluten is reintroduced. Expand
Elevated gliadin antibody levels in individuals with schizophrenia
  • O. Okusaga, R. Yolken, +11 authors T. Postolache
  • Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2013
TLDR
This study confirmed an association between anti-gliadin IgG antibodies and schizophrenia, limited by its cross sectional design, which could lead to novel treatment targets, preventive and therapeutic considerations in schizophrenia. Expand
Serological Tests in Gluten Sensitivity (Nonceliac Gluten Intolerance)
TLDR
The serological pattern of GS is characterized by IgG AGA positivity in more than half of cases associated to IgA AGA in a few patients, but without EmA, tTGA, and DGP-AGA, which are the specific markers of celiac disease. Expand
A study of circulating gliadin antibodies in schizophrenia among a Chinese population.
TLDR
Quantitative analysis demonstrated that the mean levels of IgA antibodies against deamidated gliadin epitopes and TGM2 were significantly lower in patients with schizophrenia than the control subjects (P < .001 and P = .008, respectively). Expand
Antibodies to wheat proteins in schizophrenia: relationship or coincidence?
TLDR
Investigation of a larger group of patients, one with an increased permeability for gliadin and with a high antigliadin titre, and the other with a low permeability and having a low titre found that there are two groups of patients. Expand
...
1
2
3
4
...